TrialJournal of Parkinson's disease2025

Continuous, subcutaneous apomorphine infusion for Parkinson disease motor fluctuations: Results from the phase 3, long-term, open-label United States InfusON study.

Stuart H Isaacson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.